Skip to main content
Equibles

Blackstone Inc.

Position in RZLT — Rezolute, Inc.

CIK 1393818 NEW YORK, NY
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,631,220
-$22,793,430 QoQ
Shares Held
1,082,927
-64.2% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 144 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Blackstone Inc. holds $252,665,757 across 52 Biotechnology names. RZLT ranks #13 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AUTL
Autolus Therapeutics plc
 20,485,611 $32,776,977
2 DFTX
Definium Therapeutics, Inc.
 561,612 $26,418,228
3 DMRA
Damora Therapeutics, Inc.
 1,002,971 $26,087,275
4 ARTV
Artiva Biotherapeutics, Inc.
 2,403,437 $23,313,338
5 ORKA
Oruka Therapeutics, Inc.
 237,108 $22,565,568
6 ALXO
Alx Oncology Holdings Inc
 6,593,543 $13,648,634
7 XFOR
X4 Pharmaceuticals, Inc
 2,681,922 $12,524,575
8 IKT
Inhibikase Therapeutics, Inc.
 5,938,276 $12,054,700

All Filings in RZLT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,631,220 1,082,927
2025-09-30 $28,424,650 3,023,899
2025-06-30 $15,878,888 3,560,289
2025-03-31 $5,059,746 1,744,740
2024-12-31 $8,549,226 1,744,740
2024-09-30 $8,461,989 1,744,740
2024-06-30 $7,501,952 1,744,640
2024-03-31 $3,921,094 1,537,684
2023-12-31 $1,526,920 1,537,684
2023-09-30 $2,029,742 1,537,684
2023-06-30 $3,044,614 1,537,684
2023-03-31 $2,952,353 1,537,684
2022-12-31 $3,183,005 1,537,684
2022-09-30 $4,213,254 1,537,684
2022-06-30 $4,966,719 1,537,684